News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and views
Campaigning
We want men with prostate cancer to get better diagnosis, better treatment and better support. But we can’t do it alone: we need your help.
Join the fightBlack men are twice as likely to be diagnosed with prostate cancer. Help us find out why.
1 in 4 black men will be diagnosed with prostate cancer in their lifetime, double the 1 in 8 risk faced by all men. We don’t know why, but you can help us find out.
Dr Matthew Hobbs is “doubly excited” by new precision medicines for advanced prostate cancer.
These precision drugs are the biggest breakthroughs we’ve seen in decades for extending the lives of men with advanced prostate cancer.
A year of leaps: 2019 was historic for prostate cancer research
The last year saw the announcement of the world’s first precision medicine for prostate cancer and huge progress towards the development of a home urine test. Just some of the things that made 2019 one of the most innovative years in prostate cancer research history.
Breakthrough: world's first precision prostate cancer treatment
This week’s results offer a brand-new precision treatment option for a group of men with particularly aggressive forms of advanced prostate cancer.
Behind the headlines: Could a new blood test for prostate cancer really end the need for biopsy?
News of a new prostate cancer test hit the headlines yesterday. It’s a promising step forward in improving diagnosis, but is there enough research to show the test could be accurate enough to end the need for biopsy?
Behind the headlines: could MRI screening become a reality for men?
The news features a ‘ten-minute MRI scan’ which could be rolled out in future across the country as part of a screening programme, and potentially give men the ‘all-clear for life’ - we take a look at the claims.
Research blog: The jigsaw is falling into place but one crucial piece is missing
BLOG: From 'seek and destroy' radiotherapy to repurposing an ovarian cancer drug, it's been a week of big news from the world's biggest cancer research conference. Dr Matthew Hobbs gives his perspective on the latest in prostate cancer and what needs to happen next.
Enzalutamide has similar benefit to chemo when taken with hormone therapy
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
New self-management programme could save NHS resources and support men better
Allowing men to access test results online provides just as good support while saving the NHS money.
Focal therapy is put to the test in new trial
Focal therapy causes fewer side effects when treating localised prostate cancer, so we’re funding a new trial to see if it’s possible to compare it against surgery and radiotherapy.